RL

Robert Lamers

CEO

Graviton Bioscience

Amsterdam, North Holland


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Graviton Bioscience
Industry
research
Employees
44.0
Seniority
C suite

Technologies

Outlook Amazon AWS Mobile Friendly Google AdSense

Keywords

biotechnology research homeostasis fibrotic diseases autoimmune diseases cns diseases novel therapies selective rock2 inhibitors clinical trials therapeutic modalities drug development molecular pathways patient outcomes translational research graft versus host disease myasthenia gravis type 1 diabetes idiopathic pulmonary fibrosis metabolic syndrome cerebral cavernous malformations amyotrophic lateral sclerosis traumatic brain injury alzheimer's disease multiple sclerosis immunology drug candidates patents research collaboration scientific publications biotech innovation targeted inhibitors kinase regulation cell signaling immune defense clinical programs clinical development healthcare innovation transparency in research drug commercialization therapeutic new areas biopharmaceuticals research partnerships medical research healthcare solutions patient-centered therapies breakthrough treatments biotech partnerships healthcare advancements therapeutic focus scientific expertise innovative drug discovery healthcare equity health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans